Aug 18, 2026 08:01AM
Jul 27, 2026 08:09AM
Jul 22, 2026 08:11AM
Jul 7, 2026 08:46AM
Jun 22, 2026 08:01AM
Jun 18, 2026 01:17PM
Jun 17, 2026 09:25AM bioAffinity Technologies prices $3.2 million public offering
Jun 16, 2026 08:06AM
May 27, 2026 08:01AM
May 12, 2026 09:15AM
Apr 1, 2026 08:01AM
Mar 13, 2026 08:01AM
Mar 3, 2026 08:31AM
Feb 25, 2026 08:31AM bioAffinity Technologies starts lung cancer test validation study
Feb 19, 2026 11:01AM
Nov 5, 2025 08:00AM
Oct 28, 2025 08:03AM
Oct 16, 2025 08:02AM
Oct 9, 2025 01:00PM
Oct 8, 2025 04:16PM
Oct 8, 2025 03:47PM bioAffinity Technologies raises $1.8 million in registered direct offering
Oct 7, 2025 08:05AM
Sep 26, 2025 08:05AM
Jul 22, 2025 09:02AM
Jul 15, 2025 09:02AM
Jun 24, 2025 09:05AM
May 28, 2025 09:01AM
May 20, 2025 09:02AM bioAffinity (BIAF) Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
May 7, 2025 01:00PM
May 6, 2025 09:26AM
Apr 17, 2025 09:19AM
Mar 31, 2025 09:28AM
Mar 6, 2025 08:03AM
Jan 22, 2025 08:01AM
Nov 4, 2024 08:02AM bioAffinity (BIAF) Appoints William Bauta as Chief Science Officer
Oct 30, 2024 08:02AM
Oct 18, 2024 12:45PM
Oct 16, 2024 08:04AM
Oct 10, 2024 08:02AM
Oct 9, 2024 08:03AM
Aug 2, 2024 09:27AM
Jul 9, 2024 08:08AM bioAffinity (BIAF) Reports 217% Sales Growth in Second Quarter 2024 for CyPath Lung

445,679 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All